Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection.
The antiviral potential of transcripts targeted to the non-coding regions (NCRs) of foot-and-mouth disease virus (FMDV) RNA have been studied during transient and constitutive expression in susceptible BHK-21 cells. Transient expression of antisense transcripts corresponding to the 5' and 3'NCRs, alone or in combination, confers specific inhibition of homologous (serotype C) virus infection in BHK-21 cells. Constitutive expression of antisense 5'NCR transcripts (5'AS) exerted higher levels of inhibition to homologous and heterologous (serotypes O, A, Asia, SAT 1, SAT 2 and SAT 3) FMDV infection, as estimated by a 10-fold reduction in virus titre in the supernatants from infected clones and by a plaque reduction assay. These inhibitions were also observed, albeit to a lesser extent, in clones stably expressing antisense 3'NCR transcripts. The antiviral response was specific for FMDV, as the picornavirus encephalomyocarditis virus was not inhibited in any of the transformed cell lines. In all cases, a correlation was found between the level of transcript expression and the extent of virus inhibition. The potential to efficiently inhibit FMDV, including isolates representing the seven serotypes, by expressing interfering 5'AS transcripts opens the possibility of developing transgenic animals with a reduced susceptibility to FMDV.
Rosas
M F
MF
Centro de Investigación en Sanidad Animal, INIA, Valdeolmos, 28130 Madrid, Spain.|Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.
Martínez-Salas
E
E
Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.
Sobrino
F
F
Centro de Investigación en Sanidad Animal, INIA, Valdeolmos, 28130 Madrid, Spain.|Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.
D020121:5' Untranslated Regions / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003588:Cytopathogenic Effect, Viral; D029544:Foot-and-Mouth Disease Virus / Q000145:classification / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development*; D016372:RNA, Antisense / Q000378:metabolism* / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism; D012703:Serotyping; D014162:Transfection; D010948:Viral Plaque Assay
D020121:5' Untranslated Regions; D016372:RNA, Antisense; D012333:RNA, Messenger; D012367:RNA, Viral